Category Archives: News

This content originally appeared on the UCLA Health Newsroom website. View the full article here.

New UCLA-led research suggests certain gut bacteria — including one that is essential for a healthy gut microbiome – differ between people who go on to acquire HIV infection compared to those who have not become infected.

The findings, published in the peer-reviewed journal eBioMedicine, suggest that the gut microbiome could contribute to one’s risk for HIV infection, said study lead Dr. Jennifer Fulcher, assistant professor of medicine, division of infectious diseases, at the David Geffen School of Medicine at UCLA.

“This is an important area that needs further research to better understand if and how these bacteria could affect HIV transmission,” said Fulcher, who also has an appointment with VA Greater Los Angeles Healthcare System. “Microbiome-based therapies are becoming a hot area of research with great potential. With further research this could be a novel way to help in HIV prevention.”

It is known that there is link between chronic HIV and changes in gut bacteria, Fulcher said. The researchers wanted to get a better understanding of when following HIV infection these changes begin to take place.

To this end, they examined gut microbiome samples from 27 men who have sex with men that were collected both before and after they became infected. They then compared those samples with 28 men who were at similar behavioral risk for infection but did not have HIV.

The samples came from the UCLA-led Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO), a resource and data center for millions of pieces of research, lab samples, statistics and other data aimed at boosting investigations into the effects of substance abuse on HIV/AIDS.

The researchers found that during the first year there was very little change in the infected men’s gut bacteria. They found, however, that the men who acquired HIV had pre-existing differences in gut bacteria, even before they became infected, compared with their uninfected counterparts.

Specifically, these men had decreased levels of Bacteroides species, a type of bacteria prevalent in the lower intestinal tract that have important metabolic functions in maintaining a healthy gut environment, and increased levels Megasphaera elsdenii, whose role in the human gut is not yet known, compared with the uninfected at-risk controls. The researchers also found that prior to infection the men who acquired HIV had elevated inflammatory cytokines and bioactive lipids, both of which are associated with systemic inflammation, indicating that their bodies were constantly on the defense against infection or injury, compared to the matched controls.

Study limitations include the relatively small sample size, and the focus being on only young men who have sex with men, most of whom use drugs, which may reduce its generalizability to other populations.

Study co-authors in addition to Fulcher are Fan Li, Dr. Nicole Tobin, Sara Zabih, Julie Elliott, Dr. Jesse Clark, Steven Shoptaw, Pamina Gorbach, and Dr. Grace Aldrovandi of UCLA; Dr. Richard D’Aquila and Brian Mustanski of Northwestern University; and Michele Kipke of Children’s Hospital Los Angeles and USC.

The study was funded by the National Institute of Allergy and Infectious Diseases (K08 AI124979,  P30 AI117943), National Institute on Drug Abuse (U01 DA036267, U01 DA036939, U01 DA036926, U24 DA044554), National Institute of Mental Health (P30 MH058107, R34 MH105272), the UCLA AIDS Institute, the UCLA Center for AIDS Research (NIAID AI028697), and the UCLA Pediatric AIDS Coalition.

September 27, 2022 – Today, CHIPTS joins partners across the U.S. in observing National Gay Men’s HIV/AIDS Awareness Day (NGMHAAD), a day dedicated to recognizing the disproportionate impact of the HIV epidemic on gay men and promoting HIV prevention and treatment services that allow gay men to live long, healthy lives. In honor of NGMHAAD, we are excited to feature a reflection from CHIPTS Combination Prevention Core Scientist Dr. Michael Li. Read Michael’s reflection below.

In observance of National Gay Men’s HIV/AIDS Awareness Day, it is important to highlight the significant impact of HIV/AIDS on the gay community since the epidemic began over 40 years ago. In recent years, advancements in antiretroviral therapy have allowed people with HIV to live full, healthy lives, and the availability of pre-exposure prophylaxis (PrEP) provides a critical tool for preventing infection. However, there is still much work to be done. HIV continues to disproportionately impact gay, bisexual, and other men who have sex with men (MSM), with findings from the Centers for Disease Control in 2020 showing that 56% percent of people with HIV and 71% of people with new HIV diagnoses are members of these populations.

Understanding the contextual factors driving HIV infections among gay men is necessary to ensure successful approaches to HIV prevention and care for this population. Gay men who experience stigma and discrimination are more likely to be unstably housed, use psychostimulants (e.g. methamphetamine), and develop mental health issues. All of these factors are linked to increased risk of acquiring HIV, reduced access to preventive services such as PrEP, and reduced access to HIV care and antiretroviral therapy. Furthermore, the impact of adverse social experiences on health may not only be explained by behavior, but possibly complex interactions between one’s social environment and the immune system. In research on diverse MSM, recent experiences of homophobia, violence, and housing instability have been linked to dysregulated pro-inflammatory and antiviral gene expression even when accounting for HIV viral load.

Intersectionality also plays a significant role in HIV prevention and healthcare engagement among gay men. How might race, ethnicity, age, disability, class, or other types of “membership” inform one’s preventive and care needs? How might experiences of intersectional stigma impact medical mistrust? As of 2017, it is estimated that about a third of MSM in the US have used PrEP. Although this represents an overall increase since 2014, Black/African American and Latinx gay and bisexual men were still less likely to discuss PrEP with their providers or use PrEP than their White peers. Similarly, though viral suppression has improved by an average of 9.4% per year since 2014, Black/African American MSM are still less likely to be virally suppressed than other MSM with HIV.

As we reflect on NGMHAAD, I encourage HIV researchers and service providers to adopt an intersectional lens and collaborate with the gay community as we work together to address HIV. In doing so, we will be better positioned to address the diverse, whole-person needs of gay, bisexual, and other MSM, and achieve key goals for Ending the HIV Epidemic in this community.

Thursday, September 22, 2022 – CHIPTS hosted a career-development webinar entitled, “Proposal Basics: Preparing Applications for Research Funding” featuring Laura Sheehan, Manager of Research Administration for the Department of Family Medicine in the David Geffen School of Medicine at UCLA. Ms. Sheehan discussed funding opportunities, the fundamentals of preparing a proposal (including creating a budget), and the lifespan of a research project from inception to close-out.

Ms. Sheehan was joined by over 80 graduate students, post-doctoral students, early/mid-career investigators from academic institutions, and others interested in learning about research proposal development. She began by providing a basic overview of the research funding process, including identifying appropriate funding opportunities, exploring different kinds of sponsors, and understanding typical proposal components. The majority of her presentation focused on essential considerations when preparing a research proposal, including tailoring research plans to specific opportunities, creating a budget, organizing your team, building a timeline for submission, and how to avoid common mistakes. She left participants with words of encouragement to “just keep swimming” if a proposal is unsuccessful – if you find the right funding mechanism, follow the guidelines closely, and write a compelling narrative, your research will get funded.

View the recorded webinar here: https://www.youtube.com/watch?v=UGHOxvFvJ_8

Download the webinar slide set here: Proposal Basics: Preparing Applications for Research Funding - Slides

Check out these great resources from Ms. Sheehan’s presentation:

• UCLA Office of Research Administration (ORA) Training Programs 
• UCLA Clinical and Translational Science Institute (CTSI) Funding Search Tools & Grant-Writing Tips
• National Institutes of Health (NIH) Grants & Funding: Developing Your Budget
• NIH Grants Basics: https://grants.nih.gov/grants/grant_basics.htm
• NIH Grants Process Overview: https://grants.nih.gov/grants/grants_process.htm
• UCLA OCGA FAQs: https://ocga.research.ucla.edu/faq/#proposal-preparation

This content originally appeared on HIV.Gov. View the full article here.

As National HIV/AIDS and Aging Awareness Day approaches on September 18, HIV.gov spoke with Harold Phillips, Director of the White House Office of National AIDS Policy. Watch the video to hear him discuss the growing population of people aging with HIV, their specific needs, and what the Federal Government is doing to support this community.

 

Mr. Phillips began by providing data about the population of people aging with HIV. He shared that more than 50% of people with diagnosed HIV are aged 50 and older. Additionally, he noted that there is an estimated 18,000 people in this same age group who have undiagnosed HIV, which significantly affects health outcomes, as they are often late getting into HIV care and treatment, compared to those who are younger.

Regardless of the frequency with which those 50 and older visit healthcare providers, they can be, as Mr. Phillips said, less likely to discuss sex and drug use behaviors with their health providers and be impacted by HIV stigma. He stressed that HIV and aging is an issue of great concern because this population also experiences special challenges and is susceptible to other conditions, such as geriatric illnesses, psychosocial needs, and other non-communicable diseases.

National HIV/AIDS Strategy Federal Implementation Plan

On August 26, 2022, the White House released the National HIV/AIDS Strategy (NHAS) Federal Implementation Plan, an important milestone in implementing the NHAS. The new Plan includes “a number of federal activities to improve the quality of life for those over 50 with HIV,” said Mr. Phillips, as he continued to expound upon what other agencies and programs—including the Health Resources & Services Administration’s (HRSA) Ryan White HIV/AIDS Program, National Institutes of Health-funded research initiatives, the Substance Abuse and Mental Health Services Administration’s (SAMHSA) work on substance use disorder, and CDC’s efforts to scale-up access to HIV testing—are doing to end the HIV epidemic in the United States.

To learn more about HIV and aging and to support National HIV/AIDS and Aging Awareness Day, watch our latest discussion with Mr. Phillips. We also encourage you to visit CDC’s HIV by Age webpage, subscribe to the HIV.gov blog, and check out other federal partner sites—like CDC, HRSA, and SAMHSA—for tools and resources to help you “think about innovative ways to reach, approach, and serve people who are over 50 and living with HIV.”

August 29, 2022 – Today, CHIPTS honors National Faith HIV/AIDS Awareness Day  (NFHAAD), a day dedicated to engaging faith communities to work together to promote HIV/AIDS education, connect those at risk with prevention and treatment services, and help address stigma and discrimination. Find more information about NFHAAD below.

 

Since 2017, Reaching All HIV+ Muslims in America (RAHMA) and its partners have led an annual observance of National Faith HIV & AIDS Awareness Day (NFHAAD) across the United States to engage people of all faiths in taking a stand against stigma in their congregations and promoting HIV education. As described by the National Faith HIV/AIDS Awareness Day Task Force:

“Many faith communities have been and are at the forefront of the response to HIV/AIDS in a variety of     ways.​ Faith communities and faith-based organizations have been and are a vital part of providing HIV/AIDS services, especially in hard-to-reach areas, and especially when government and community-based organizations were slow to act in the early days of the epidemic. Unfortunately, some faith communities can also be environments for perpetuating misinformation and reinforcing stigma and discrimination against people living with or at risk for HIV​…We pray that each of our faith communities can be a welcoming and safe place for any person with HIV/AIDS and an uplifting environment that will support people’s use of effective HIV prevention.”

Many faith-based leaders and advocates are leading transformative conversations in their communities and supporting interventions to end the HIV epidemic. One group working to bridge HIV and faith is the HIV Vaccine Trials Network (HVTN) Faith Initiative. This national program engages Faith Ambassadors across the U.S. to connect with diverse faith communities and share evidence-based information about HIV.

HVTN Faith Ambassadors have written a series of reflections offering different religious perspectives and sharing personal experiences around HIV and faith. Check out a few of their reflections below:

• “The Intersection of Faith and Science,” Donata Morrison, PhD / HVTN Faith Ambassador – The Intersection of Faith and Science (hvtn.org)

• “Faith Community Engagement – A Latinx Muslim Perspective,” Sultana Ocasio/ HVTN Faith Ambassador – Faith Community Engagement – A Latinx Muslim Perspective (hvtn.org)

• “The Body of Christ has HIV,” Ulysses W. Burley, MD, MPH/ HVTN Faith Ambassador – The Body of Christ has HIV (hvtn.org)

• “Tie Your Camel First, and Then put Your Trust in Allah,” Khadijah Abdullah/ HVTN Faith Ambassador – Tie Your Camel First, and Then put Your Trust in Allah” (hvtn.org)

Learn more about National Faith HIV & AIDS Awareness Day and opportunities to get involved today.

This content originally appeared on HHS Press Office. View the full article here.

The funding will expand HIV prevention, testing, and treatment services at health centers nationwide.

[On August 23, 2022], at the National Ryan White Conference on HIV Care and Treatment, U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra announced more than $20 million in funding to expand HIV prevention, testing, and treatment services at health centers nationwide. The funding – awarded by the Health Resources and Services Administration (HRSA) to 64 health centers – is part of HHS’ Ending the HIV Epidemic in the U.S. (EHE) initiative, which aims to reduce the number of new HIV infections in the U.S. by 90 percent by 2030.

“Community health centers are critical to preventing and treating HIV, especially when it comes to reaching underserved communities,” said HHS Secretary Xavier Becerra. “Today’s awards will ensure high quality HIV prevention, testing, and treatment services are more readily available for Americans who need it the most.”

Health centers who receive this funding will leverage it to expand access to medication to prevent HIV (including Pre-Exposure Prophylaxis or PrEP and related services), connect people to care, and ensure care services are well coordinated. They will also leverage it to strengthen partnerships with community organizations such as HRSA’s Ryan White HIV/AIDS Program-funded organizations and health departments. Stronger partnerships speed up patients’ connections to prevention services, including testing and PrEP.

“We have the tools to end the HIV epidemic in the U.S., including testing and medication to prevent and treat HIV. Yet, tools alone won’t end the epidemic – we need to support trusted community leaders in their work to engage people in care,” said HRSA Administrator Carole Johnson. “Today’s awards make these critical investments by building on HRSA’s longstanding support for the Ryan White HIV/AIDS Program to expand our HIV prevention and treatment work in community health centers.”

Partnerships and action are even more important as the U.S. faces a monkeypox (MPx) outbreak. As part of the monkeypox outbreak response, the Biden-Harris Administration launched a national strategy to provide vaccines of MPx for individuals at higher risk of exposure. HRSA’s Ryan White HIV/AIDS Program has begun allocating an initial allotment of vaccines for people with HIV, people who are low income, and those who are uninsured.

“We have many of the tools necessary to substantially curb the HIV epidemic in the United States,” said Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, part of the NIH. “This funding award is an important contribution to ensuring that vital HIV testing, prevention tools, treatment and access to care reach the local communities where they can have the most impact.”

The funding announced today builds on over $100 million in previously awarded EHE funding to more than 300 health centers, and will fund additional health centers in the counties, territories, and states identified as a part of the EHE initiative. The EHE initiative supports President Biden’s National HIV/AIDS Strategy 2022-2025, which extends across many federal departments and encompasses the entire nation. The EHE initiative is a leading component of HHS’ work – in collaboration with state, tribal, territorial, and local partners – to implement the Strategy.

See a list of today’s award recipients: https://bphc.hrsa.gov/funding/funding-opportunities/primary-care-hiv-prevention/fy-2022-awards.

For more information about HRSA’s role in the EHE initiative, visit: www.hrsa.gov/ending-hiv-epidemic.

To locate a HRSA Health Center Program supported health center, visit: https://findahealthcenter.hrsa.gov/.

This content originally appeared on HIV.gov. View the full article here.

“I am a Work of ART,” the national viral suppression campaign recently launched by the Office of Infectious Disease and HIV/AIDS Policy (OIDP), was introduced to an international community of researchers, practitioners, advocates, and people with HIV at the International AIDS Society’s AIDS 2022 conference  in Montreal earlier this month.

The vibrant, life-affirming campaign encourages people with HIV who are not in care, or in and out of care, to seek care, get into care, and achieve viral suppression through antiretroviral therapy, also known as ART. Playing off of the dual meaning of “art,” the campaign encourages people to find a provider that is right for them by visiting HIV.gov/ART so they can, as one of the campaign’s creative partners says, “stay healthy and untransmittable so we can have the freedom to pursue our passions.”

The campaign was first introduced to AIDS 2022 in the Global Village and Youth Programme  during a hybrid session with conference participants joining both in person and virtually. The session explored innovative community engagement strategies used in viral suppression campaigns seeking to re-engage people in marginalized communities.

Assistant Secretary for Health, ADM Rachel Levine, MD, opened the session with her personal perspective on the journey from the early years of the HIV epidemic to today, where viral suppression through ART is now a reality for millions of people with HIV. B. Kaye Hayes, MPA, Director of OIDP and Deputy Assistant Secretary for Infectious Disease, then took the podium to introduce the “I am a Work of ART” campaign, highlighting how the national viral suppression campaign helps to fill the gap in public education campaigns by focusing on engaging people with HIV who are not in care.

Director Hayes highlighted the co-creation of the campaign with a diverse group of people with HIV—the campaign’s creative partners—who share their experiences of getting into HIV care, starting ART, and achieving and maintaining viral suppression, helping them to live healthy lives. (See Director Hayes talking with HIV.gov about the “I am a Work of ART” campaign in this video conversation  at AIDS 2022.)

Co-creation was at the heart of developing “I am a Work of ART,” and the campaign team was able to feature the stories of our creative partners at the AIDS 2022 conference by premiering a video of them telling their stories during a roundtable discussion in Miami, FL, on June 18. In this video, each of the creative partners talk about their journey from diagnosis to living life as a work of ART because they have achieved viral suppression, with HIV being undetectable and therefore untransmittable (U=U).

The U=U message was launched in 2016 by the Prevention Access Campaign and has been communicated widely by medical, scientific, and public health institutions worldwide. During AIDS 2022, it was announced that the U.S. Federal Government has adopted U=U to further guide HIV treatment and prevention efforts. This announcement means that the U=U message will be embedded in the nation’s policy and programming efforts across the board. See ONAP’s Harold Phillips discuss “I am a Work of ART” and the U.S. Government’s adoption of U=U at AIDS 2022.

During the Global Village Q&A facilitated by Dr. Tammy Henry, senior training and technical assistance specialist with the campaign team, participants shared their various perspectives based on their work in in Australia, South Africa, and the U.S. In fact, as one participant pointed out, a similar campaign that plays on the dual meaning of ART, “Modern ART Across South Africa ,” is currently being implemented by the Treatment Action Campaign and HIV i-Base UK with funding from Unitaid.

Finally, the “I am a Work of ART” campaign was a part of the U.S. Government/U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) exhibit in the conference exhibit hall. Eye-catching panels featuring two of the campaign’s models—Jasmine and TBoy—helped draw participants to the booth. Dr. Tammy Henry and Patrick Cook, senior communication manager with the campaign team, guided visitors through the campaign and, in the scheduled “ask the expert” session on August 1st, fielded questions about the fundamentals of the campaign, how it was developed, and its current implementation status.

The “I am a Work of ART” campaign is currently in eight cities across the country—

Atlanta, Baltimore, Cleveland, Dallas, Los Angeles, Miami, Tulsa, and Washington, DC—as well as in other communities focused on viral suppression among people with HIV. But anyone from any community can use the campaign’s messages and materials to encourage viral suppression. Campaign materials feature 10 different creative partners and include video and audio public service announcements, posters, and flyers, as well as rack and business cards. In the coming months, the campaign will release new campaign materials in Spanish to broaden the focus of the campaign.

If you are looking for a provider in your area to start ART or if you are looking for more information about the campaign or to download materials, please visit HIV.gov/ART.

The “AIDS DIVA: The Legend of Connie Norman” film screening and advocacy panel was held on Thursday, June 30, 2022 at the UCLA Fowler Museum from 6 to 8pm.  The community event was planned and organized by the UCLA CHIPTS Community Advisory Board in partnership with UCLA Family AIDS Network, REACH LA, and Northeast Valley Health Corporation. The film was selected because it gave a historical overview of AIDS Advocacy in Los Angeles County through the life story of Connie Norman, a leader of ACT-UP.   The film aimed to motivate and encourage those in attendance to be ready to speak up about issues that improve prevention and treatment of HIV/AIDS as well as LGBTQ rights.

The hosts were thrilled to host 60 attendees – community members, students, and representatives from AIDS service organizations such as the Black AIDS Institute, JWCH Institute, Bienestar, Watts Health Corporation and more, to be inspired by a powerful documentary that brought LGBT rights and HIV Advocacy to the forefront.

The event was moderated by James Aboagye and Eddie Sanders, CAB Co-chairs of the CHIPTS CAB, a  group of community leaders and advocates, who advise CHIPTS scientists on research, dissemination of results and other activities that are relevant to the lives of diverse communities impacted by HIV/AIDS.

The event concluded with a reflective discussion session led by the film’s advocacy panel consisting of Dante Alencastre, award-winning documentary filmmaker and LGBT community activist, Rabbi Robyn Podolsky, Los Angeles Program Manager for At The Well organization, and Tony Newman, Interim Chief Executive Officer and President for the Black AIDS Institute. See panel members’ biographies below.

To learn more about the film, AIDS Diva, visit the website: https://www.aidsdivaconnie.com/

Panelists Biographies

The advocacy panel consisted of Dante Alencastre, Film Maker, Rabbi Robin Podoloky, and Toni Newman, Executive Director and Advocate.

• Dante Alencastre is an award-winning documentary filmmaker and LGBT community activist based in West Hollywood.  His filmmaking and work on the boards of Los Angeles LGBT arts organizations, and political and community groups is focused particularly on the overlapping Latinx Transgender and Gender non-conforming sub-tribes within the community. He is currently director of the California LGBT Arts Alliance. Dante found his personal calling documenting the lives of LGBT individuals and communities during a trip to his native Peru, resulting in the 2007 award-winning filmEn El Fuego (In the Fire ) (2007) (LA Outfest Audience Award), and later, El Fuego Dentro (The Fire Inside) ( 2012), documenting the lives and struggles of a group of trans activists in Lima.  Dante’s film,Transvisible: Bamby Salcedo’s Story ( 2013), documented the powerful Trans Latina activist embarking on her community-based work. Raising Zoey (2016 ) follows the story of  a 13-year-old Latina trans girl and her highly supportive mother, through discrimination towards advocacy. Both premiered at Outfest and toured widely. This film, AIDS DIVA: The Legend of Connie Norman (2021) revives a remarkable figure in AIDS activism and early trans advocacy and her continuing influence on her surviving activist colleagues today.
• Rabbi Robyn Podolsky is the Los Angeles Program Manager for At The Well, a Jewish women’s wellness organization. She was interviewed in the film as a former ACT-UP LA member and someone who had worked alongside Connie. Robin serves on the Board of Governors for the Sandra Caplan Community Bet Din, writes at TribeHerald and jewishjournal.com, and serves as writing facilitator and dramaturg for Queerwise, a spoken word and writing group. Her most recent academic article, “Sumud Freedom Camp: Levinas’ Face-to-Face in Praxis” was published in Religions, Vol.10, No. 4. She conducts workshops, rituals and study sessions, for Jewish holidays and other occasions, that combine modalities: text study, personal work and small group sharing, writing (except on Shabbat and Yom Tov), prayer and meditation.
• Tony Newman is the Interim Chief Executive Officer and President for the Black AIDS Institute Black AIDS Institute (BAI). She was the Interim President for LYRIC, and a faculty member at the Transgender Strategy Center and Chair of the Board of Directors for TransCanWork. Toni is a graduate of Wake Forest University and current candidate for her Juris of Doctorate (JD). Toni was the Interim Director of Employment Services at the SF LGBT Center, Executive Director for St. James Infirmary and the Director of Development for Maitri Compassionate Care, and previously served as the Interim Director of Development & Communications at To Help Everyone Health and Wellness Centers and as a Strategic Fundraiser, Volunteer Recruiter, and Legislative Aide for Equality California. Additionally, Toni is a best selling author, noted for her memoir I Rise -The Transformation of Toni Newman released in 2011. Her memoir was based on the poem I Rise by Wake Forest University Reynolds Professor, Dr. Maya Angelou, who Toni interviewed with in 2012. She and her partner are currently working on a feature film, Heart of a Woman, based on her memoir I Rise.

 

 

 

 

The California HIV/AIDS Policy Research Center (CHPRC) in collaboration with the Center for HIV Identification, Prevention and Treatment Services (CHIPTS) shared some newly published findings that are both exciting and impactful to efforts of ending the HIV epidemic and beyond. This published paper and accompanying infographic, is the first to examine the relationship between a state Earned Income Tax Credit (EITC) and HIV risk behaviors among single mothers in the United States.

The Journal of AIDS & Behavior published a paper authored by Drs. Kimberly Narain, MD, PhD and Nina Harawa, PhD, MPH, entitled “Evidence for the Role of State-Level Economic Policy in HIV Risk Reduction: State Earned Income Tax Credit Generosity and HIV Risk Behavior Among Single Mothers.” The paper looks at the generosity of the state Earned Income Tax Credit in the United States and HIV risks behavior among single mothers.

In the United States, the generosity of each state’s EITC differs from each other, with many states lacking an EITC. In states with more generous EITCs, the study found, HIV risk behaviors decreased significantly  in single mothers compared with single mothers in other states with less generous EITCs. The effect of a refundable state EITC on HIV risk behavior was what we would expect for two or more hours of intensive HIV risk-reduction counseling, an intervention few low-income single mothers can readily access.

These findings demonstrate the impact of anti-poverty policy interventions: the straightforward act of distributing cash aid to those in need. These policies became more common during the pandemic, but have expired in many cases. For example, the monthly Child Tax Credit which lifted millions of children from poverty (source). Additionally, a reduction in HIV risk behaviors lowers the risk for other ailments such as pelvic inflammatory disease, cervical cancer, and liver cancer.

The published paper may be accessed by following this link. Additionally, CHIPTS has created an accompanying infographic, in collaboration with the California HIV/AIDS Policy Research Center (CHPRC). The infographic entitled “HIV Risk Reduction & Earned Income Tax Credit, ” provides insight on the following:

• What is an EITC, and which states provide it?
• What is the difference between refundable and non-refundable EITC, and why is this important?
• How generous does a state EITC have to be to reduce HIV risk behaviors?
• What other risk behaviors are reduced by cash assistance programs like EITC?

Note: The finding of a negative association between state Earned Income Tax Credit generosity and a composite measure of HIV risk behavior is particularly important given that the population observed in this study is at high risk for contracting HIV.

Please find a copy of the infographic and additional resources, available for download below:

• Infographic: HIV Risk Reduction & Earned Income Tax Credit - Infographic
• Publication: SpringerLink
• Website: https://www.chprc.org/

——————————————-

We hope that you can review the infographic and publication and share the important findings with your networks. Help us circulate this important work to your networks! Share on social media below:

Share on Twitter & Facebook (Retweet), Create your own social media posts using the suggested language below:

Twitter:

NEW Infographic from @CHIPTS and @ca_hiv_policyrc: Single mothers in U.S. states with more a generous Earned Income Tax Credit (EITC) engaged in significantly less #HIV risk behaviors compared to those in states with less generous (or nonexistent) EITCs, demonstrating the benefits of #antipoverty policy.

Facebook:

NEW Infographic from @CHIPTS and @ca_hiv_policyrc: Single mothers in U.S. states with more generous Earned Income Tax Credits (EITC) engaged in significantly less #HIV risk behaviors compared to those in states with less generous (or nonexistent) EITCs. The effect of a refundable state EITC on HIV risk behavior was what we would expect for two or more hours of intensive HIV risk-reduction counseling, an intervention few low-income single mothers can readily access. This finding demonstrates the impact of #antipoverty policy.

July 8th, 2022 – Our partners at UCLA Center for Behavioral and Addiction Medicine (CBAM) and Charles R. Drew University of Medicine and Science (CDU) in collaboration with the California Community Foundation (CCF) are excited to share a newly published report entitled, “Equity and Access: A Roadmap to Improving Vaccination Equity in South Los Angeles,” that advises and provides insights on how to reach communities of color and those hardly reached to educate, build trust, and disseminate vaccines in South Los Angeles given historical experiences with medical mistrust.

This community-based study identified inequities and how these inequities interfere with access to COVID-19 vaccines for Black and Latina/o/x communities in South Los Angeles. The project focused on three goals, which are to:

• Facilitate community, public, private, and governmental partnerships to reduce COVID-19 vaccine inequity.
• Educate communities of color in South LA about the COVID-19 vaccines through virtual town halls.
• Navigate communities of color in South LA on how to access available COVID-19 vaccines.

The study systematically gathered perspectives and experiences around COVID-19 vaccination access and equity from three key groups in South Los Angeles: community members (i.e., essential workers), community leaders (i.e., clergy, faith-based leaders, and leaders of community-based organizations), and community providers (i.e., clinicians and clinical providers) for our focus groups and community education summits.

The findings in this report are intended to guide efforts to enhance engagement with key stakeholders, and to help build capacity of community and public agencies to be better positioned to provide a timely response to future public health emergencies.

Views, opinions, and comments expressed by the participants are those of the particular individual speaking and do not necessarily represent the views and opinions of other participants, the research team, or the funder.

Please find a copy of the report and additional resources, available for download below:.

• Report: Equity and Access: A Roadmap to Improving Vaccination Equity in South Los Angeles
• Community Resource Guide: COVID-19 Community Resource Guide
• Project Webpage: https://chipts.ucla.edu/covid-19-vaccine-accessibility-initiative/